China NMPA Drug Inspection - The other 10 companies (see attached list for details) - 11 batches of medicines
China NMPA drug inspection for The other 10 companies (see attached list for details) published September 11, 2020. Drug: 11 batches of medicines. On September 11, 2020, the Gansu Provincial Drug Administration, operating under the framework of the National Medical P
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for The other 10 companies (see attached list for details) published September 11, 2020. Drug: 11 batches of medicines. On September 11, 2020, the Gansu Provincial Drug Administration, operating under the framework of the National Medical P
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox